{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T09:16:58Z","timestamp":1767950218025,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015471","name":"Mater Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015471","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015626","name":"Melanoma Institute Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015626","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001102","name":"Cancer Council New South Wales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejso.2025.111163","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T09:09:56Z","timestamp":1763111396000},"page":"111163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Accuracy of PET\/CT in the diagnosis of pelvic lymph node metastases in melanoma: A subgroup analysis of the prospective, randomised, phase III Evaluation of groin lymphadenectomy extent for metastatic melanoma (EAGLE-FM) trial"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9594-022X","authenticated-orcid":false,"given":"Michael","family":"Russell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Emmett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Peric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3354-806X","authenticated-orcid":false,"given":"Robyn PM.","family":"Saw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Spillane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinicius","family":"Vasquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joao","family":"Duprat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4492-235X","authenticated-orcid":false,"given":"Marc","family":"Moncrieff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Allan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rowan","family":"Pritchard-Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Rastrelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6773-9668","authenticated-orcid":false,"given":"Johannes","family":"de Wilt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Bertolli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Sommariva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Geh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Howle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8354-434X","authenticated-orcid":false,"given":"Andrew","family":"Spillane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.ejso.2025.111163_bib1","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1245\/s10434-012-2483-3","article-title":"Surgeons' opinions on lymphadenectomy in melanoma patients with positive sentinel nodes: a worldwide web-based survey","volume":"19","author":"Pasquali","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2025.111163_bib2","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1445-2197.2008.04716.x","article-title":"Ilioinguinal lymph node dissection for palpable metastatic melanoma to the groin","volume":"78","author":"Allan","year":"2008","journal-title":"ANZ J Surg"},{"issue":"1","key":"10.1016\/j.ejso.2025.111163_bib3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/bjs.10644","article-title":"Optimal extent of completion lymphadenectomy for patients with melanoma and a positive sentinel node in the groin","volume":"105","author":"Verver","year":"2018","journal-title":"Br J Surg"},{"issue":"12","key":"10.1016\/j.ejso.2025.111163_bib4","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1245\/s10434-010-1203-0","article-title":"The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the multicenter selective lymphadenectomy trial (I)","volume":"17","author":"Faries","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2025.111163_bib5","unstructured":"Saw, R., Menzies, A., McArthur, G., Spillane, J., & Haydon, A. Cancer council Australia melanoma guidelines working party. Clinical question: what investigations should be performed when in transit and\/or regional node disease (stage III melanoma) is diagnosed? . In: Clinical practice guidelines for the diagnosis and management of melanoma. Sydney: Melanoma Institute Australia. [Version URL: https:\/\/wiki.cancer.org.au\/australiawiki\/index.php?oldid=186475,cited2023Mar21].Availablefrom: https:\/\/wiki.cancer.org.au\/australia\/Guidelines:Melanoma."},{"issue":"3","key":"10.1016\/j.ejso.2025.111163_bib6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10434-999-0263-5","article-title":"Does extent of operation influence the prognosis of patients with melanoma metastatic to inguinal nodes","volume":"6","author":"Mann","year":"1999","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2025.111163_bib7","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1046\/j.1365-2168.2000.01439.x","article-title":"Prognosis and surgical management of patients with palpable inguinal lymph node metastasis from melanoma","volume":"87","author":"Hughes","year":"2000","journal-title":"Br J Surg"},{"issue":"23","key":"10.1016\/j.ejso.2025.111163_bib8","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion dissection or observation for sentinel node metastasis in melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ejso.2025.111163_bib9","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1470-2045(16)00141-8","article-title":"Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial","volume":"17","author":"Leiter","year":"2016","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2025.111163_bib10","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1470-2045(21)00065-6","article-title":"Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG\/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial","volume":"22","author":"Eggermont","year":"2021","journal-title":"Lancet Oncol"},{"issue":"19","key":"10.1016\/j.ejso.2025.111163_bib11","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","article-title":"Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma","volume":"377","author":"Weber","year":"2017","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.ejso.2025.111163_bib12","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa1708539","article-title":"Adjuvant dabrafenib plus trametinib in stage III BRAF-mutated melanoma","volume":"377","author":"Long","year":"2017","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ejso.2025.111163_bib13","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S1470-2045(19)30151-2","article-title":"Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial","volume":"20","author":"Rozeman","year":"2019","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2025.111163_bib14","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/s41591-018-0198-0","article-title":"Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma","volume":"24","author":"Blank","year":"2018","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.ejso.2025.111163_bib15","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41591-018-0197-1","article-title":"Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma","volume":"24","author":"Amaria","year":"2018","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.ejso.2025.111163_bib16","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S1470-2045(19)30331-6","article-title":"Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAFv600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial","volume":"20","author":"Long","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2025.111163_bib17","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41591-022-01851-x","article-title":"Personalised response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial","volume":"28","author":"Reijers","year":"2022","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.ejso.2025.111163_bib18","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/SLA.0b013e31824a5742","article-title":"Cost-effectiveness of adding FDG-PET or CT to the diagnostic workup of patients with stage III melanoma","volume":"255","author":"Bastiaannet","year":"2012","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ejso.2025.111163_bib19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jnci\/djq455","article-title":"Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis","volume":"103","author":"Xing","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.ejso.2025.111163_bib20","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1245\/s10434-016-5142-2","article-title":"The diagnostic value of PET\/CT imaging in melanoma groin metastases","volume":"23","author":"Van Wissen","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2025.111163_bib21","doi-asserted-by":"crossref","unstructured":"Lee, T., Li, I., Peric, B., Saw R., Duprat, J., et al. Leg lymphoedema after inguinal and olio-inguinal lymphadenectomy for melanoma: results from a prospective, randomised trial. Ann Surg Oncol. 31(6): 4061-4070.","DOI":"10.1245\/s10434-024-15149-4"},{"key":"10.1016\/j.ejso.2025.111163_bib22","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1056\/NEJMoa2211437","article-title":"Neoadjuvant-adjuvant or adjuvant only pembrolizumab in advanced melanoma","volume":"388","author":"Patel","year":"2023","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ejso.2025.111163_bib23","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/00000658-199805000-00017","article-title":"Effectiveness of positron emission tomography for the detection of melanoma metastases","volume":"227","author":"Holder","year":"1998","journal-title":"Ann Surg"},{"issue":"7","key":"10.1016\/j.ejso.2025.111163_bib24","article-title":"Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma","volume":"7","author":"Dinnes","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.ejso.2025.111163_bib25","first-page":"1420","article-title":"Initial assessment of positron emission tomography using 2-fluorine-18-fluroro-2-deoxy-D-glucose in the imaging of malignant melanoma","volume":"34","author":"Gritters","year":"1993","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ejso.2025.111163_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40644-021-00440-4","article-title":"PET\/CT variants and pitfalls in malignant melanoma","volume":"23","author":"Aide","year":"2022","journal-title":"Cancer Imaging"},{"issue":"6","key":"10.1016\/j.ejso.2025.111163_bib27","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1007\/s00259-008-1049-x","article-title":"Diagnostic accuracy of contrast-enhanced FDG-PET\/CT in primary staging of cutaneous malignant melanoma","volume":"36","author":"Veit-Haibach","year":"2009","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.ejso.2025.111163_bib28","doi-asserted-by":"crossref","unstructured":"Schwartz, L., Litiere S., Vries E De, Ford, R., Gwyther, S., Mandrekar, S., et al. RECIST 1.1-Update and clarification: from the RECIST committee. Eur J Cancer. 62: 132-137.","DOI":"10.1016\/j.ejca.2016.03.081"},{"issue":"1","key":"10.1016\/j.ejso.2025.111163_bib29","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2967\/jnumed.114.145029","article-title":"Update on time-of-flight PET imaging","volume":"56","author":"Surti","year":"2015","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.ejso.2025.111163_bib30","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2214\/AJR.19.22705","article-title":"Total-body PET\/CT: current applications and future perspectives","volume":"215","author":"Tan","year":"2020","journal-title":"Am J Roentgenol"},{"issue":"12","key":"10.1016\/j.ejso.2025.111163_bib31","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1245\/s10434-019-07274-2","article-title":"Early recurrence in completely resected IIB and IIIC melanoma warrants restaging prior to adjuvant therapy","volume":"26","author":"Bloemendal","year":"2019","journal-title":"Ann Surg Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325015914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325015914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T07:57:45Z","timestamp":1767945465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798325015914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0748798325015914"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2025.111163","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Accuracy of PET\/CT in the diagnosis of pelvic lymph node metastases in melanoma: A subgroup analysis of the prospective, randomised, phase III Evaluation of groin lymphadenectomy extent for metastatic melanoma (EAGLE-FM) trial","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2025.111163","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111163"}}